Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Jinling Hospital, China
Tampere University Hospital
The Netherlands Cancer Institute
Centre Hospitalier Universitaire de Tivoli
Emory University
Emory University
M.D. Anderson Cancer Center